BHCM
TMDX icon

Brevan Howard Capital Management’s Transmedics TMDX Stock Holding History

Brevan Howard Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,761
Closed -$944K – 2491
2025
Q4 		$944K Sell
7,761
-9,719
-56% -$1.22M 0.01% 799
2025
Q3 		$1.96M Buy
17,480
+7,129
+69% +$835K 0.01% 571
2025
Q2 		$1.39M Buy
+10,351
New +$1.14M 0.01% 912
2025
Q1 		– Sell
-10,114
Closed -$631K – 1458
2024
Q4 		$631K Buy
+10,114
New +$941K ﹤0.01% 555

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's TMDX Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 7,761 shares — an estimated $944K sold.

Brevan Howard Capital Management first reported a position in TMDX in Q4 2024 and held it in 4 quarters. The position peaked at $1.96M in Q3 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 7,761 Transmedics shares in Q1 2026, an estimated $944K.
  • Brevan Howard Capital Management first reported a position in Transmedics in Q4 2024 and held it in 4 quarters.
  • Brevan Howard Capital Management's Transmedics position peaked at $1.96M in Q3 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.